Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$71.58 - $87.29 $437,926 - $534,040
-6,118 Reduced 59.23%
4,211 $308,000
Q4 2023

Feb 06, 2024

BUY
$73.27 - $83.09 $50,116 - $56,833
684 Added 7.09%
10,329 $836,000
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $1,330 - $1,452
18 Added 0.19%
9,645 $722,000
Q1 2023

May 03, 2023

SELL
$77.31 - $88.08 $71,125 - $81,033
-920 Reduced 8.72%
9,627 $798,000
Q4 2022

Feb 06, 2023

BUY
$62.32 - $89.47 $102,890 - $147,714
1,651 Added 18.56%
10,547 $905,000
Q3 2022

Nov 09, 2022

BUY
$59.54 - $68.01 $14,944 - $17,070
251 Added 2.9%
8,896 $549,000
Q2 2022

Aug 08, 2022

BUY
$57.72 - $65.01 $64,530 - $72,681
1,118 Added 14.85%
8,645 $534,000
Q1 2022

May 04, 2022

SELL
$57.92 - $72.58 $57,572 - $72,144
-994 Reduced 11.67%
7,527 $447,000
Q4 2021

Feb 04, 2022

BUY
$64.88 - $73.64 $31,466 - $35,715
485 Added 6.04%
8,521 $619,000
Q3 2021

Oct 26, 2021

BUY
$67.69 - $73.03 $40,004 - $43,160
591 Added 7.94%
8,036 $561,000
Q2 2021

Jul 21, 2021

BUY
$63.47 - $69.35 $41,953 - $45,840
661 Added 9.74%
7,445 $513,000
Q1 2021

Apr 28, 2021

BUY
$60.0 - $68.46 $48,180 - $54,973
803 Added 13.43%
6,784 $438,000
Q4 2020

Feb 02, 2021

BUY
$56.65 - $64.55 $21,583 - $24,593
381 Added 6.8%
5,981 $348,000
Q3 2020

Nov 09, 2020

BUY
$62.1 - $78.08 $347,760 - $437,248
5,600 New
5,600 $354,000
Q2 2019

Aug 07, 2019

SELL
$61.87 - $69.38 $20,045 - $22,479
-324 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$62.53 - $70.05 $10,317 - $11,558
-165 Reduced 33.74%
324 $21,000
Q4 2018

Jan 16, 2019

BUY
$60.54 - $79.0 $23,186 - $30,257
383 Added 361.32%
489 $31,000
Q3 2018

Oct 30, 2018

BUY
$71.28 - $78.92 $5,346 - $5,919
75 Added 241.94%
106 $8,000
Q2 2018

Jul 17, 2018

SELL
$64.88 - $75.68 $10,056 - $11,730
-155 Reduced 83.33%
31 $2,000
Q1 2018

Apr 12, 2018

BUY
$72.84 - $88.8 $364 - $444
5 Added 2.76%
186 $13,000
Q4 2017

Feb 09, 2018

BUY
$71.15 - $83.52 $12,878 - $15,117
181
181 $12,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Legacy Financial Advisors, Inc. Portfolio

Follow Legacy Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.